IP Library Granted Patent US 8,765,195
Granted Patent B2
US 8,765,195 · App. 13/623,115 · Granted Jul 1, 2014

Methods and compositions for increasing sex steroids and growth hormones

Inventors: Amy L. Heaton (Salt Lake City, UT); Mitchell K. Friedlander (Salt Lake City, UT); Dennis Gay (Salt Lake City, UT)
Assignee: Quality IP Holdings, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,765,195
App. No.
13/623,115
Granted
Jul 1, 2014
Kind
B2
Abstract

Embodiments of the invention generally relate to methods and supplements for increasing sex steroids and human growth hormone in a human being.

Claims (24)

1. A method of increasing sex steroids and human growth hormone in a human being, comprising:

providing an oral nutritional supplement consisting essentially of:

about 1 mmol L-arginine, about 1 mmol Oxo-proline, about 2 mmol L-lysine, about 1.5 μmol N-acetyl L-cysteine, about 2 μmol L-glutamine, and about 125 μg Schizonepta (aerial parts) powder; and

orally administering the nutritional supplement to a human being exhibiting one or more symptoms of post-traumatic stress disorder orally administering the nutritional supplement to the human being in an amount effective to: increase lean body mass; reduce obesity, adipose tissue mass, or anxiety; support weight loss; decrease appetite and atrophic processes in skeletal muscle, liver, kidney, spleen, skin, or bone; improve energy, endurance, sleep, metabolism, heart rate, blood pressure, cardiovascular health, sympathetic nervous activity, thyroid response, fat metabolism, glucose utilization, mental/cognitive function, reaction time, bone density, hair health and appearance, nail health and appearance, skin health and appearance, or libido; and/or affect one or more condition(s) and/or disease(s) that depend upon androgen activity.

2. The method of claim 1 , wherein the nutritional supplement is present in an amount of 2.9 grams.

3. The method of claim 1 , wherein the nutritional supplement is in powder, tablet, capsule, liquid, or wafer form.

4. The method of claim 1 , wherein the nutritional supplement is administered from one to three times daily.

5. The method of claim 1 , wherein the nutritional supplement is administered on an empty stomach.

6. The method of claim 1 , wherein the human is at least 30 years old.

7. A method of increasing sex steroids and human growth hormone in a human being, comprising:

providing an oral nutritional supplement consisting essentially of:

0.86 mmol L-arginine;

1.32 mmol Oxo-proline;

2.05 mmol L-lysine;

1.53 mmol N-acetyl L-cysteine;

1.71 μmol L-glutamine; and

125 μg Schizonepta (aerial parts) powder; and

orally administering the nutritional supplement to the human being in an amount effective to: increase lean body mass or libido; reduce obesity, adipose tissue mass, or anxiety; support weight loss; decrease appetite and atrophic processes in skeletal muscle, liver, kidney, spleen, skin, or bone; improve energy, endurance, sleep, metabolism, heart rate, blood pressure, cardiovascular health, sympathetic nervous activity, thyroid response, fat metabolism, glucose utilization, mental/cognitive function, reaction time, bone density, hair health and appearance, nail health and appearance, skin health and appearance, or libido; and/or affect one or more condition(s) and/or disease(s) that depend upon androgen activity.

8. The method of claim 7 , wherein the nutritional supplement is present in an amount of 2.9 grams.

9. The method of claim 7 , wherein the nutritional supplement is in powder, tablet, capsule, liquid, or wafer form.

10. The method of claim 7 , wherein the nutritional supplement is administered from one to three times daily.

11. The method of claim 7 , wherein the nutritional supplement is administered once a week.

12. The method of claim 7 , wherein the nutritional supplement is administered on an empty stomach.

13. The method of claim 7 , wherein the human is at least 30 years old.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2023
From: CASPAR CAPITAL LP
To: QUALITY IP HOLDINGS LLC
Reel/Frame 062283/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: CERBERUS BUSINESS FINANCE, LLC
To: CASPAR CAPITAL LP
Reel/Frame 061636/0625 →
ASSIGNMENT OF SECURITY INTEREST Recorded Dec 30, 2019
From: LS2, LLC
To: CERBERUS BUSINESS FINANCE, LLC
Reel/Frame 051447/0114 →
SECURITY INTEREST Recorded Aug 21, 2015
From: QUALITY IP HOLDINGS, LLC
To: LS2, LLC
Reel/Frame 036392/0053 →
ASSIGNMENT FOR SECURITY - PATENTS Recorded Dec 4, 2014
From: QUALITY IP HOLDINGS, LLC
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 034535/0294 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF ASSIGNEE FROM QUALITY IP HOLDINGS, INC. TO QUALITY IP HOLDINGS, LLC PREVIOUSLY RECORDED ON REEL 032089 FRAME 0942. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT NAME OF THE ASSIGNEE IS QUALITY IP HOLDINGS, LLC.. Recorded Aug 8, 2014
From: HEATON, AMY L.; FRIEDLANDER, MITCHELL K.; GAY, DENNIS
To: QUALITY IP HOLDINGS, LLC
Reel/Frame 033501/0323 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2014
From: HEATON, AMY L.; FRIEDLANDER, MITCHELL K.; GAY, DENNIS
To: QUALITY IP HOLDINGS, INC.
Reel/Frame 032089/0942 →
Continuity (1)
Related Publication 20140079829A1 · Mar 20, 2014